Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions
Northwest Women's and Children's Hospital, Xi'an, Shaanxi · Infertility
Not applicable
Recruiting
792
2025-12
Evidence dashboardStudies since 2007Updated Jul 31, 2026
AtosibanClinical Trials.
A source-linked view of every Atosiban study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
- Total trials
- 23
- Recruiting
- 3
- Completed
- 12
- Terminated
- 1
- Results posted
- 2
- Average enrollment
- 227
- Countries
- 22
- Highest phase
- Phase 4
Largest indexed study
800 participants · NCT01501214 →Developer / research origin
Ferring Pharmaceuticals
Evidence summary
Activity is not efficacy.
Atosiban appears in 23 indexed studies: 3 recruiting, 12 completed and 2 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Atosiban is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Recruiting or active
Completed studies
Finished records
Stopped studies
Withdrawn or terminated
NCT IDStudyPhase / statusEnrollmentUpdated
The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )
University of Electronic Science and Technology of China · Healthy Adult Male
Early Phase 1
Recruiting
250
2025-09
The Effect of Oral Oxytocin and Atosiban on Social Attention
University of Electronic Science and Technology of China · Healhty
Early Phase 1
Recruiting
250
2025-07
NCT IDStudyPhase / statusEnrollmentUpdated
Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm Birth(sPTB)
Children's Hospital of Chongqing Medical University · Cervical Cerclage · Premature Birth
Not applicable
Completed
334
2025-05
Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Preterm Birth
Phase 4
Completed
760
2024-07
In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline
University of Sao Paulo General Hospital · Myelomeningocele · Terbutaline Adverse Reaction
Not applicable
Completed
25
2022-06
Oxytocin Antagonist in Patients With Repeated Failure of Implantation
AZ Jan Palfijn Gent · Implantation Failure
Phase 4
Completed
138
2021-02
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
GlaxoSmithKline · Obstetric Labour, Premature
Phase 3
Completed
98
2020-07
Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth
Polish Mother Memorial Hospital Research Institute · Premature Birth
Not applicable
Completed
64
2019-06
Showing 6 of 12 studies
NCT IDStudyPhase / statusEnrollmentUpdated
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour
GlaxoSmithKline · Obstetric Labour, Premature
Phase 3
Terminated
97
2020-07
Nifedipine Treatment in Preterm Labor
Hospital Clinico Universitario de Santiago · Threatened Preterm Labor
Phase 3
Withdrawn
0
2014-07
Full study index
Search Atosiban trials.
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
23 matching studies
Last registry update first
Latest publications
Follow the paper trail.
PMID 42229962 ↗Cai H, Li W, Mol BWJ, Liu D, Lei D, Ran X, Zhang D, Xue X, Gao L, Shi J. Randomised, triple-blind, placebo-controlled trial of atosiban in women with previous embryo implantation failure and abnormal uterine contractions undergoing single blastocyst-stage embryo transfer: a study protocol. BMJ Open. 2026 Jun 2;16(6):e114029. doi: 10.1136/bmjopen-2025-114029.Linked from NCT07185230PMID 31772083 ↗Klumper J, Breebaart W, Roos C, Naaktgeboren CA, van der Post J, Bosmans J, van Kaam A, Schuit E, Mol BW, Baalman J, McAuliffe F, Thornton J, Kok M, Oudijk MA. Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study. BMJ Open. 2019 Nov 26;9(11):e029101. doi: 10.1136/bmjopen-2019-029101.Linked from NCT05693688PMID 23508219 ↗Ferschl M, Ball R, Lee H, Rollins MD. Anesthesia for in utero repair of myelomeningocele. Anesthesiology. 2013 May;118(5):1211-23. doi: 10.1097/ALN.0b013e31828ea597.Linked from NCT04468568PMID 18481813 ↗Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, Meyer R, Canfield MA, Mulinare J; National Birth Defects Prevention Network. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008 Jul;82(7):527-32. doi: 10.1002/bdra.20468.Linked from NCT04468568PMID 18417993 ↗Fichter MA, Dornseifer U, Henke J, Schneider KT, Kovacs L, Biemer E, Bruner J, Adzick NS, Harrison MR, Papadopulos NA. Fetal spina bifida repair--current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther. 2008;23(4):271-86. doi: 10.1159/000123614. Epub 2008 Apr 14.Linked from NCT04468568PMID 21306277 ↗Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004. doi: 10.1056/NEJMoa1014379. Epub 2011 Feb 9.Linked from NCT04468568PMID 11605920 ↗Fisk NM, Gitau R, Teixeira JM, Giannakoulopoulos X, Cameron AD, Glover VA. Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling. Anesthesiology. 2001 Oct;95(4):828-35. doi: 10.1097/00000542-200110000-00008.Linked from NCT04468568PMID 11892506 ↗Cauldwell CB. Anesthesia for fetal surgery. Anesthesiol Clin North Am. 2002 Mar;20(1):211-26. doi: 10.1016/s0889-8537(03)00062-2.Linked from NCT04468568
Related pages
Keep researching Atosiban.
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.